Correlation Between Mersana Therapeutics and Travere Therapeutics
Can any of the company-specific risk be diversified away by investing in both Mersana Therapeutics and Travere Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mersana Therapeutics and Travere Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mersana Therapeutics and Travere Therapeutics, you can compare the effects of market volatilities on Mersana Therapeutics and Travere Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mersana Therapeutics with a short position of Travere Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mersana Therapeutics and Travere Therapeutics.
Diversification Opportunities for Mersana Therapeutics and Travere Therapeutics
0.23 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Mersana and Travere is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Mersana Therapeutics and Travere Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Travere Therapeutics and Mersana Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mersana Therapeutics are associated (or correlated) with Travere Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Travere Therapeutics has no effect on the direction of Mersana Therapeutics i.e., Mersana Therapeutics and Travere Therapeutics go up and down completely randomly.
Pair Corralation between Mersana Therapeutics and Travere Therapeutics
Given the investment horizon of 90 days Mersana Therapeutics is expected to under-perform the Travere Therapeutics. In addition to that, Mersana Therapeutics is 3.02 times more volatile than Travere Therapeutics. It trades about -0.37 of its total potential returns per unit of risk. Travere Therapeutics is currently generating about 0.11 per unit of volatility. If you would invest 1,718 in Travere Therapeutics on October 21, 2024 and sell it today you would earn a total of 119.00 from holding Travere Therapeutics or generate 6.93% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mersana Therapeutics vs. Travere Therapeutics
Performance |
| Timeline |
| Mersana Therapeutics |
| Travere Therapeutics |
Mersana Therapeutics and Travere Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mersana Therapeutics and Travere Therapeutics
The main advantage of trading using opposite Mersana Therapeutics and Travere Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mersana Therapeutics position performs unexpectedly, Travere Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Travere Therapeutics will offset losses from the drop in Travere Therapeutics' long position.| Mersana Therapeutics vs. Terns Pharmaceuticals | Mersana Therapeutics vs. Amylyx Pharmaceuticals | Mersana Therapeutics vs. Acumen Pharmaceuticals | Mersana Therapeutics vs. Inozyme Pharma |
| Travere Therapeutics vs. Cytokinetics | Travere Therapeutics vs. Ventyx Biosciences | Travere Therapeutics vs. Cogent Biosciences | Travere Therapeutics vs. Nuvalent |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |